Gemcitabine-Incorporated G-Quadruplex Aptamer for Targeted Drug Delivery into Pancreas Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gemcitabine-Incorporated G-Quadruplex Aptamer for Targeted Drug Delivery into Pancreas Cancer

Published:2018-09 Issue: Volume:12 Page:543-553
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Park Jun Young,Cho Ye Lim,Chae Ju Ri,Moon Sung Hwan,Cho Won Gil,Choi Yun Jung,Lee Soo Jin,Kang Won Jun

Funder

Korea Health Industry Development Institute

Ministry of Health & Welfare

National R&D Program for Cancer Control, Ministry of Health and Welfare

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference56 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J. Clin.,2015

2. Recent progress in pancreatic cancer;Wolfgang;CA Cancer J. Clin.,2013

3. Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy?;Ueno;Br. J. Cancer,2007

4. Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma;Maréchal;Clin. Cancer Res.,2009

5. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines;Mackey;Cancer Res.,1998

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamer-mediated therapeutic strategies provide a potential approach for cancer;International Immunopharmacology;2024-07

2. Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia;Cancer Letters;2024-04

3. Aptamers as an approach to targeted cancer therapy;Cancer Cell International;2024-03-16

4. G-Quadruplexes in the Regulation of Viral Gene Expressions and Their Impacts on Controlling Infection;Pathogens;2024-01-08

5. Nanocarrier-mediated delivery targeting for pancreatic cancer;Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3